LABE Plastic Surgery Songdo, Incheon, Korea

ms-icon-310x310

IBEX Hyperbaric Oxygen

LABE PLASTIC SURGERY
in Korea, Incheon, Songdo Korea

IBEX Hyperbaric Oxygen Therapy (HBOT) delivers high-concentration oxygen in a pressurized chamber, allowing oxygen to dissolve directly into plasma and enhancing oxygen delivery to tissues.
This increased oxygen availability supports cellular metabolism and tissue recovery under medical supervision using protocols up to 2 ATA.

What is
IBEX Hyperbaric Oxygen Therapy?

LABE PLASTIC SURGERY
in Korea, Incheon, Songdo Korea

IBEX Hyperbaric Oxygen Therapy (HBOT) is a medical treatment that delivers high-concentration oxygen in a pressurized environment to support tissue recovery and cellular function. By increasing atmospheric pressure inside a hyperbaric chamber, a higher amount of oxygen can be dissolved into the bloodstream and delivered to tissues throughout the body.

At LABE Plastic Surgery, HBOT is performed using the IBEX hyperbaric chamber, with treatment protocols reaching 2 atmospheres absolute (2 ATA) under controlled medical supervision.

How Does IBEX Hyperbaric Oxygen Therapy Work?

LABE PLASTIC SURGERY
in Korea, Incheon, Songdo Korea

During treatment, the patient rests inside the IBEX M2 chamber while the internal pressure is gradually increased to 2 ATA, and high-concentration oxygen is administered.

The IBEX system is designed to maintain stable pressure control while minimizing discomfort during pressurization and depressurization.

Increased pressure allows oxygen to dissolve directly into plasma

Oxygen delivery to tissues is enhanced beyond normal breathing levels

Oxygen availability supports cellular metabolism and tissue recovery

Treatment parameters are automatically controlled for safety and comfort

Benefits of IBEX Hyperbaric Oxygen Therapy

LABE PLASTIC SURGERY
in Korea, Incheon, Songdo Korea

HBOT is often incorporated as part of a comprehensive recovery or regenerative care plan rather than as a standalone cosmetic treatment.

Enhances oxygen delivery to tissues and cells

Supports wound healing and tissue recovery

Helps improve circulation and cellular metabolism

May aid recovery after surgery or regenerative treatments

Non-invasive therapy performed in a controlled environment

Uses a medical-grade chamber with standardized pressure protocols

Why Choose LABE for IBEX Hyperbaric Oxygen Therapy?

LABE PLASTIC SURGERY
in Korea, Incheon, Songdo Korea

At LABE Plastic Surgery, IBEX Hyperbaric Oxygen Therapy is performed using two IBEX medical-grade hyperbaric chambers, allowing flexible scheduling and consistent treatment availability. All treatments are conducted under the supervision of a board-certified plastic surgeon, with protocols carefully selected and pressurization reaching 2 ATA based on individual condition and therapeutic goals.

LABE brings extensive clinical experience with HBOT, supported by academic presentations and professional discussions at medical conferences, reflecting a deep understanding of hyperbaric oxygen therapy in clinical practice. Rather than applying a standardized approach, LABE emphasizes patient safety, precise pressure control, and thoughtful integration of HBOT with surgical, laser, or regenerative procedures to support optimal recovery and tissue health.

Board-Certified Plastic Surgeon

Dr. HYUNG JUN MIN

ABOVE & BEYOND in ANTI-AGING & WELLNESS

“Sincerity, passion, and a dedication to true beauty—
Creating exceptional experiences for every patient.”

Integrated Regenerative Treatments with IBEX Hyperbaric Oxygen Therapy

At LABE Plastic Surgery, IBEX Hyperbaric Oxygen Therapy (HBOT) can be thoughtfully combined with regenerative treatments as part of an integrated care approach. In particular, undergoing MCT MetaCell treatment after IBEX HBOT and subsequent blood collection may be beneficial. Hyperbaric oxygen therapy helps optimize the body’s oxygen-rich environment, which can support cellular activity and tissue condition prior to blood-based regenerative procedures.

Following HBOT, blood is collected and processed for MCT MetaCell, allowing the treatment to be applied in a physiologic state that may enhance regenerative signaling. This sequential approach reflects LABE’s strategy of coordinating therapies to support recovery and regeneration rather than applying treatments in isolation.